IDiyas

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Brian Raimundo

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 117(Granted Patents)


Location History:

  • San Francisco, CA (US) (2002 - 2020)
  • Boston, MA (US) (2023 - 2024)

Company Filing History:

goldMedal8 out of 63 
 
Sunesis Pharmaceuticals, Inc.
 patents
silverMedal4 out of 850 
 
Millennium Pharmaceuticals Limited
 patents
bronzeMedal4 out of 29 
 
Valo Health, Inc.
 patents
4. 1 out of 126 
 
Tularik Limited
 patents
5. 1 out of 216 
 
Biogen Idec Ma Inc.
 patents
6. 1 out of 1 
 
Integral Health, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2002-2024

where 'Filed Patents' based on already Granted Patents

14 patents (USPTO):
1. 12116362 - Monocyclic compounds useful as GPR120 modulators (2024-10-15),
2. 11919891 - Bicyclic compounds useful as GPR120 modulators (2024-03-05),
3. 11548886 - Monocyclic compounds useful as GPR120 modulators (2023-01-10),
4. 10865201 - Bicyclic compounds useful as GPR120 modulators (2020-12-15),
5. 10800773 - Monocyclic compounds useful as GPR120 modulators (2020-10-13),
6. 9920048 - Substituted pyrimidines for inhibiting Raf kinase activity (2018-03-20),
7. 8802657 - Compounds useful as Raf kinase inhibitors (2014-08-12),
8. 8293752 - Compounds useful as Raf kinase inhibitors (2012-10-23),
9. 7968536 - Heterocyclic compounds useful as RAF kinase inhibitors (2011-06-28),
10. 7767687 - Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors (2010-08-03),
11. 7115654 - Caspase-1 inhibitors and methods for their use (2006-10-03),
12. 6806279 - Small-molecule inhibitors of interleukin-2 (2004-10-19),
13. 6426331 - Inhibitors of STAT function (2002-07-30),
14. 6376524 - Triphenyl compounds as interleukin-4 antagonists (2002-04-23),

Title: The Innovative Journey of Brian Raimundo

Introduction

Brian Raimundo is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate GPR120 activity. With a total of 14 patents to his name, Raimundo's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents are "Monocyclic compounds useful as GPR120 modulators" and "Bicyclic compounds useful as GPR120 modulators." These patents detail compounds and compositions that can modulate GPR120 activity, offering methods for treating diseases mediated by this receptor. The innovative nature of these compounds showcases Raimundo's commitment to advancing medical science.

Career Highlights

Raimundo has worked with notable companies in the pharmaceutical industry, including Sunesis Pharmaceuticals, Inc. and Millennium Pharmaceuticals Limited. His experience in these organizations has allowed him to hone his skills and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Raimundo has collaborated with talented individuals such as Jennifer Cossrow and Hiroko Tanaka. These partnerships have fostered an environment of innovation and creativity, leading to the successful development of new therapeutic compounds.

Conclusion

Brian Raimundo's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…